Gilliland, Labcorp director, sells $529k in stock

Published 01/08/2025, 13:48
Gilliland, Labcorp director, sells $529k in stock

Dwight Gary Gilliland, a director of Labcorp Holdings Inc (NYSE:LH), sold 2,000 shares of common stock on July 30, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a price of $264.95, for a total transaction value of $529,900. The sale comes at a time when the $21.6 billion healthcare services provider maintains a "GOOD" financial health score according to InvestingPro data, with management actively pursuing share buybacks.

Following the transaction, Gilliland directly owns 6,656 shares of Labcorp. The sale was reported on August 1, 2025. While the stock typically demonstrates low price volatility, InvestingPro analysis indicates the company is currently trading near its Fair Value. For deeper insights into Labcorp’s valuation and future prospects, investors can access the comprehensive Pro Research Report, available exclusively on InvestingPro.

In other recent news, Laboratory Corporation of America reported strong financial results for the second quarter of 2025, surpassing analysts’ expectations. The company achieved an adjusted earnings per share of $4.35, exceeding the forecasted $4.17, and recorded revenue of $3.53 billion, above the anticipated $3.48 billion. Following these results, several analyst firms have adjusted their outlooks for Labcorp. Jefferies raised its price target to $300.00 from $290.00, maintaining a Buy rating, citing a 1% top-line beat driven by the Base Business segment. Evercore ISI also increased its price target to $300.00 from $285.00, maintaining an Outperform rating, noting strong diagnostic growth. Additionally, Leerink Partners raised its price target to $323.00 from $293.00, highlighting strength in Labcorp’s diagnostics business and biopharma laboratory services division. These developments reflect a positive sentiment among analysts regarding Labcorp’s recent performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.